A
Angela White
Researcher at GlaxoSmithKline
Publications - 24
Citations - 817
Angela White is an academic researcher from GlaxoSmithKline. The author has contributed to research in topics: European union & Process (engineering). The author has an hindex of 13, co-authored 24 publications receiving 635 citations.
Papers
More filters
Journal ArticleDOI
In silico toxicology protocols.
Glenn J. Myatt,Ernst Ahlberg,Yumi Akahori,David Allen,Alexander Amberg,Lennart T. Anger,Aynur O. Aptula,Scott S. Auerbach,Lisa Beilke,Phillip Bellion,Romualdo Benigni,Joel P. Bercu,Ewan D. Booth,Dave Bower,Alessandro Brigo,Natalie Burden,Zoryana Cammerer,Mark T. D. Cronin,Kevin P. Cross,Laura Custer,Magdalena Dettwiler,Krista L. Dobo,Kevin A. Ford,Marie C. Fortin,Samantha E. Gad-McDonald,Nichola Gellatly,Véronique Gervais,Kyle P. Glover,Susanne Glowienke,Jacky Van Gompel,Steve Gutsell,Barry Hardy,James Harvey,Jedd Hillegass,Masamitsu Honma,Jui-Hua Hsieh,Chia Wen Hsu,K. Hughes,Candice Y. Johnson,Robert A. Jolly,David Jones,Ray Kemper,Michelle O. Kenyon,Marlene T. Kim,Naomi L. Kruhlak,Sunil Kulkarni,Klaus Kümmerer,Penny Leavitt,Bernhard Majer,Scott A. Masten,Scott Miller,Janet Moser,Moiz Mumtaz,Wolfgang Muster,Louise Neilson,Tudor I. Oprea,Grace Patlewicz,Alexandre Paulino,Elena Lo Piparo,Mark Powley,Donald P. Quigley,M. Vijayaraj Reddy,Andrea Richarz,Patricia Ruiz,Benoît Schilter,Rositsa Serafimova,Wendy Simpson,Lidiya Stavitskaya,Reinhard Stidl,Diana Suarez-Rodriguez,David T. Szabo,Andrew Teasdale,Alejandra Trejo-Martin,Jean Pierre Valentin,Anna Vuorinen,Brian A. Wall,Pete Watts,Angela White,Joerg Wichard,Kristine L. Witt,Adam Woolley,David Woolley,Craig Zwickl,Catrin Hasselgren +83 more
TL;DR: The publication presents a novel approach for determining the reliability of in silico predictions alongside experimental data and discusses how to determine the level of confidence in the assessment based on the relevance and reliability of the information.
Journal ArticleDOI
Use of in silico systems and expert knowledge for structure-based assessment of potentially mutagenic impurities
Andreas Sutter,Alexander Amberg,Scott Boyer,Alessandro Brigo,Joseph F. Contrera,Laura Custer,Krista L. Dobo,Véronique Gervais,Susanne Glowienke,Jacky Van Gompel,Nigel Greene,Wolfgang Muster,John Nicolette,M. Vijayaraj Reddy,Véronique Thybaud,Esther Vock,Angela White,Lutz Müller +17 more
TL;DR: The procedures presented here for structure-based assessment are considered appropriate for regulatory submissions in the scope of ICH M7 and a rule-based expert system complemented by either expert knowledge or a second (Q)SAR model is appropriate.
Journal ArticleDOI
Interlaboratory evaluation of a flow cytometric, high content in vitro micronucleus assay
Steven M. Bryce,Svetlana L. Avlasevich,Jeffrey C. Bemis,Magdalena Lukamowicz,Azeddine Elhajouji,Freddy Van Goethem,Marlies De Boeck,Dominiek Beerens,Hilde Aerts,Jacky Van Gompel,Joanne E. Collins,Patricia Ellis,Angela White,Anthony M. Lynch,Stephen D. Dertinger +14 more
TL;DR: Results indicate that rapid assessment of genotoxicity can be accomplished with a relatively simple flow cytometric technique, and that the scoring system is transferable across laboratories, and may help reduce the occurrence of irrelevant positive results.
Journal ArticleDOI
Principles and procedures for implementation of ICH M7 recommended (Q)SAR analyses.
Alexander Amberg,Lisa Beilke,Joel P. Bercu,Dave Bower,Alessandro Brigo,Kevin P. Cross,Laura Custer,Krista L. Dobo,Eric Dowdy,Kevin A. Ford,Susanne Glowienke,Jacky Van Gompel,James Harvey,Catrin Hasselgren,Masamitsu Honma,Robert A. Jolly,Raymond Kemper,Michelle O. Kenyon,Naomi L. Kruhlak,Penny Leavitt,Scott Miller,Wolfgang Muster,John Nicolette,Andreja Plaper,Mark Powley,Donald P. Quigley,M. Vijayaraj Reddy,Hans-Peter Spirkl,Lidiya Stavitskaya,Andrew Teasdale,Sandy Weiner,Dennie S. Welch,Angela White,Joerg Wichard,Glenn J. Myatt +34 more
TL;DR: This paper outlines a series of principles and procedures to consider when generating (Q)SAR assessments aligned with the ICH M7 guideline to be included in a regulatory submission.
Journal ArticleDOI
In silico methods combined with expert knowledge rule out mutagenic potential of pharmaceutical impurities: an industry survey.
Krista L. Dobo,Nigel Greene,Charlotta Fred,Susanne Glowienke,James Harvey,Catrin Hasselgren,Robert A. Jolly,Michelle O. Kenyon,Jennifer B. Munzner,Wolfgang Muster,Robin Neft,M. Vijayaraj Reddy,Angela White,Sandy Weiner +13 more
TL;DR: To assess how confident the authors can be in identifying non-mutagenic structures, eight companies were surveyed and the Negative Predictive Value (NPV) of the in silico approaches was 94%.